NCT07165938 Genetics of Neonatal Encephalopathy and Related Disorders
| NCT ID | NCT07165938 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston Children's Hospital |
| Condition | Neonatal Encephalopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2026-02-04 |
| Primary Completion | 2035-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2026-02-04 with a primary completion date of 2035-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Investigators at Boston Children's Hospital are conducting research in order to better understand the genetic factors which may contribute to neonatal encephalopathy (NE) and related disorders. These findings may help explain the broad spectrum of clinical features and outcomes seen in individuals with a history of NE.
Eligibility Criteria
Proband Criteria: Inclusion Criteria: * Diagnosed with neonatal encephalopathy during the neonatal period as documented in the electronic medical record * Less than 6 years old at the time of study enrollment * Patient at Boston Children's Hospital Exclusion Criteria: * Genetic cause of NE already identified * Deceased prior to enrollment Parent criteria: Inclusion Criteria: \- Biological parent of eligible proband (see above)
Frequently Asked Questions
Who can join the NCT07165938 clinical trial?
This trial is open to participants of all sexes, studying Neonatal Encephalopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07165938 currently recruiting?
Yes, NCT07165938 is actively recruiting participants. Visit ClinicalTrials.gov or contact Boston Children's Hospital to inquire about joining.
Where is the NCT07165938 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07165938 clinical trial?
NCT07165938 is sponsored by Boston Children's Hospital. The trial plans to enroll 300 participants.